Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death
Authors:
- Jixin WangJWJixin Wang
- Sanjay K. SinghSSSanjay K. Singh
- David A. GutmanDGDavid A. Gutman
- Pascal O. ZinnPZPascal O. Zinn
- 1 April 2015
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 275 (1) , 215-227
Abstract
To identify the molecular profiles of cell death as defined by necrosis volumes at magnetic resonance (MR) imaging and uncover sex-specific molecular signatures potentially driving oncogenesis and cell death in glioblastoma (GBM). This retrospective study was HIPAA compliant and had institutional review board approval, with waiver of the need to obtain informed consent. The molecular profiles for 99 patients (30 female patients, 69 male patients) were identified from the Cancer Genome Atlas, and quantitative MR imaging data were obtained from the Cancer Imaging Archive. Volumes of necrosis at MR imaging were extracted. Differential gene expression profiles were obtained in those patients (including male and female patients separately) with high versus low MR imaging volumes of tumor necrosis. Ingenuity Pathway Analysis was used for messenger RNA-microRNA interaction analysis. A histopathologic data set (n = 368; 144 female patients, 224 male patients) was used to validate the MR imaging findings by assessing the amount of cell death. A connectivity map was used to identify therapeutic agents potentially targeting sex-specific cell death in GBM. Female patients showed significantly lower volumes of necrosis at MR imaging than male patients (6821 vs 11 050 mm(3), P = .03). Female patients, unlike male patients, with high volumes of necrosis at imaging had significantly shorter survival (6.5 vs 14.5 months, P = .01). Transcription factor analysis suggested that cell death in female patients with GBM is associated with MYC, while that in male patients is associated with TP53 activity. Additionally, a group of therapeutic agents that can potentially be tested to target cell death in a sex-specific manner was identified. The results of this study suggest that cell death in GBM may be driven by sex-specific molecular pathways.Keywords
This publication has 53 references indexed in Scilit:
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010Neuro-Oncology, 2013
- Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapyThe Pharmacogenomics Journal, 2013
- Sex Differences at Cellular Level: “Cells Have a Sex”2012
- Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple MyelomaCancer Epidemiology, Biomarkers & Prevention, 2011
- Gender-Specific Genomic Profiling in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil and OxaliplatinPharmacogenomics, 2010
- Gender-specific aspects in the clinical presentation of cardiovascular diseaseFundamental & Clinical Pharmacology, 2010
- An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer PatientsPLOS ONE, 2008
- Epidemiology and molecular pathology of gliomaNature Clinical Practice Neurology, 2006
- Gene Expression Profile of Glioblastoma Multiforme Invasive Phenotype Points to New Therapeutic TargetsNeoplasia, 2005
- Genetic Pathways to GlioblastomaCancer Research, 2004